Clinical Trials Search Results

Display:

Title

Description with: Locations Eligibility

Full Trial Description

Custom

?

Hide Search Criteria

Show Search Criteria

Drug: BCMA-specific CAR-expressing T lymphocytes
Find trials that include: Any drugs shown

Results 1-4 of 4 for your search:

Start Over

Select All on Page Sort by: Show Results per Page

1.

BCMA-specific CAR-expressing T lymphocytes in Treating Patients with Previously Treated Multiple Myeloma

Status: Active
Phase: Phase I
Type: Treatment
Age: 18 to 70
Trial IDs: 14-C-0168, NCI-2014-02308, P141526, NCT02215967

2.

Genetically Engineered T Cells in Treating Patients with Relapsed and/or Refractory Multiple Myeloma

Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: UPCC 14415, NCI-2015-01595, bjcdacda, NCT02546167

3.

Study of bb2121 in Multiple Myeloma

Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CRB-401, NCI-2015-02108, NCT02658929

4.

BCMA-Specific CAR-Expressing T Lymphocytes after Cyclophosphamide in Treating Patients with Progressive, Persistent, or Refractory Multiple Myeloma or Plasma Cell Leukemia

Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 17-025, NCI-2017-00543, NCT03070327

Select All on Page

Start Over